Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (31-40 of 304) with videos related to

Pageof 31
Sort By:
Cancer Immunology, Immunotherapy : CII|June 15, 2012
The expression, function, and clinical relevance of B7 family members in cancerBarbara Seliger, Dagmar Quandt
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant DiseaseBarbara Seliger, Soldano Ferrone
Seminars in Cancer Biology|January 8, 2004
The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapiesJürgen Bukur, Barbara Seliger
Frontiers in Immunology|September 1, 2022
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapiesBarbara Seliger, Ulrike Koehl
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2013
Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilitiesChiara Massa, Barbara Seliger
Oncoimmunology|July 1, 2024
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanomaYuan Wang, Barbara Seliger
Cancer Immunology, Immunotherapy : CII|February 15, 2015
"Tumor immunology meets oncology" (TIMO) X, May 23-24, 2014, Halle/Saale, GermanyDagmar Quandt, Barbara Seliger
Briefings in Functional Genomics & Proteomics|July 9, 2004
Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analysesBarbara Seliger, Rudolf Lichtenfels, Roland Kellner
Cancer Immunology, Immunotherapy : CII|February 7, 2020
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, GermanyAndré Steven, Chiara Massa, Barbara Seliger
Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano Ferrone
Pageof 31

Showing results (31-40 of 304) with videos related to

Sort By:
Pageof 31
Cancer Immunology, Immunotherapy : CII|June 15, 2012
The expression, function, and clinical relevance of B7 family members in cancerBarbara Seliger, Dagmar Quandt
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant DiseaseBarbara Seliger, Soldano Ferrone
Seminars in Cancer Biology|January 8, 2004
The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapiesJürgen Bukur, Barbara Seliger
Frontiers in Immunology|September 1, 2022
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapiesBarbara Seliger, Ulrike Koehl
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2013
Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilitiesChiara Massa, Barbara Seliger
Oncoimmunology|July 1, 2024
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanomaYuan Wang, Barbara Seliger
Cancer Immunology, Immunotherapy : CII|February 15, 2015
"Tumor immunology meets oncology" (TIMO) X, May 23-24, 2014, Halle/Saale, GermanyDagmar Quandt, Barbara Seliger
Briefings in Functional Genomics & Proteomics|July 9, 2004
Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analysesBarbara Seliger, Rudolf Lichtenfels, Roland Kellner
Cancer Immunology, Immunotherapy : CII|February 7, 2020
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, GermanyAndré Steven, Chiara Massa, Barbara Seliger
Oncoimmunology|March 28, 2017
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevanceBarbara Seliger, Matthias Kloor, Soldano Ferrone
Pageof 31